The State of Artificial Intelligence-based FDA-approved Medical Devices and Algorithms: an Online Database
Overview
Affiliations
At the beginning of the artificial intelligence (AI)/machine learning (ML) era, the expectations are high, and experts foresee that AI/ML shows potential for diagnosing, managing and treating a wide variety of medical conditions. However, the obstacles for implementation of AI/ML in daily clinical practice are numerous, especially regarding the regulation of these technologies. Therefore, we provide an insight into the currently available AI/ML-based medical devices and algorithms that have been approved by the US Food & Drugs Administration (FDA). We aimed to raise awareness of the importance of regulatory bodies, clearly stating whether a medical device is AI/ML based or not. Cross-checking and validating all approvals, we identified 64 AI/ML based, FDA approved medical devices and algorithms. Out of those, only 29 (45%) mentioned any AI/ML-related expressions in the official FDA announcement. The majority (85.9%) was approved by the FDA with a 510(k) clearance, while 8 (12.5%) received de novo pathway clearance and one (1.6%) premarket approval (PMA) clearance. Most of these technologies, notably 30 (46.9%), 16 (25.0%), and 10 (15.6%) were developed for the fields of Radiology, Cardiology and Internal Medicine/General Practice respectively. We have launched the first comprehensive and open access database of strictly AI/ML-based medical technologies that have been approved by the FDA. The database will be constantly updated.
A bibliometric analysis of the advance of artificial intelligence in medicine.
Lin M, Lin L, Lin L, Lin Z, Yan X Front Med (Lausanne). 2025; 12:1504428.
PMID: 40061376 PMC: 11885233. DOI: 10.3389/fmed.2025.1504428.
Modise L, Alborzi Avanaki M, Ameen S, Celi L, Chen V, Cordes A PLOS Digit Health. 2025; 4(3):e0000495.
PMID: 40036250 PMC: 11878906. DOI: 10.1371/journal.pdig.0000495.
Antonoudiou P, Basu T, Maguire J Neuroinformatics. 2025; 23(2):23.
PMID: 40032704 PMC: 11876212. DOI: 10.1007/s12021-025-09719-4.
Strategies for promoting neurovascularization in bone regeneration.
Li X, Zhao Y, Miao L, An Y, Wu F, Han J Mil Med Res. 2025; 12(1):9.
PMID: 40025573 PMC: 11874146. DOI: 10.1186/s40779-025-00596-1.
Artificial intelligence in the management of metabolic disorders: a comprehensive review.
Anwar A, Rana S, Pathak P J Endocrinol Invest. 2025; .
PMID: 39969797 DOI: 10.1007/s40618-025-02548-x.